Effect of Administration of Phaleria Macrocarpa on Liver Function of Nasopharyngeal Carcinoma Patients who Receive Cisplatin Chemotherapy


  • Adi Januar Akbar ENT Department of Diponegoro University/ Dr. Kariadi Hospital, Semarang
  • Willy Yusmawan ENT Department of Diponegoro University/ Dr. Kariadi Hospital, Semarang
  • Farokah Farokah ENT Department of Diponegoro University/ Dr. Kariadi Hospital, Semarang
  • Nur Iman Nugroho ENT Department of Diponegoro University/ Dr. Kariadi Hospital, Semarang


Background: Nasopharyngeal cancer (NPC) is a malignant tumor located in the nasopharynx, which can be treated by Cisplatin, a chemotherapy that has a side effect of increasing the production of Reactive Oxygen Species (ROS) that can damage the liver. We aim to determine the effect of giving Mahkota Dewa (Phaleria macrocarpa) as an antioxidant on liver function of NPC patients receiving Cisplatin chemotherapy.

Subjects and Method: Forty subjects of stage III and IV Nasopharyngeal Carcinoma patients were divided into treatment and control groups. Subjects will be tested for SGOT SGPT before cisplatin chemotherapy. The treatment group was given Phaleria macrocarpa capsules 300 mg/24 hours for 5 weeks since a week before chemotherapy. The control group was given placebo capsules/24 hours for 5 weeks since a week before chemotherapy. The patients received two series of cisplatin chemotherapy with an interval of 3 weeks, then a second blood sample was taken 1 week after the second series of cisplatin chemotherapy.

Results: There was a significant difference in SGOT levels in the post-treatment group of Phaleria macrocarpa and control, as well as the difference in the pre- and post- treatment group between the Phaleria macrocarpa and control groups. Also, there was a significant difference in SGPT levels in the pre- and post- treatment in the Phaleria macrocarpa and control groups.

Conclusion: The administration of Phaleria macrocarpa has an effect on decreasing the levels of SGOT and SGPT in NPC patients receiving Cisplatin chemotherapy therapy

Keywords: Phaleria macrocarpa, SGOT, SGPT, Nasopharyngeal Carcinoma, Cisplatin

Correspondence: Adi Januar Akbar. ENT Department of Diponegoro University. Prof. Sudarto Street No. 13, Tembalang, Tembalang Sub-district, Semarang City, Central Java, 50275. Email: diaz17akbarsaleh­@gmail.com. +628161455179.

Indonesian Journal of Medicine (2022), 07(01): 1-8


Adham M, Kurniawan AN, Muhtadi AI, Roezin A, Hermani B, Gondhowiardjo S, Tan IB, et al. (2012). Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentation. Chin J Cancer. 31(4):185196. DOI: 10.5732/cjc.011.10328.

Alara OR, Alara JA, Olalere OA. (2016). Review on Phaleria macrocarpa Pharmacological and Phytochemical Properties. Drug Des. 5:134.

Altaf R, Asmawi MB, Dewa A, Sadikun A, Umar M. (2013). Phytochemistry and medicinal properties of Phaleria macrocarpa (Scheff.) Boerl. extracts. PharmacognRev. 7(1):73. DOI: 10.4103/09737847.112853.

Asrity A, Tsan FY, Ding P, Aris S. (2018). Functional Properties of Phaleria macrocarpa Fruit Flesh at Different ripeness. Int Food Res J. 25(3):1273–80.

Azad A, Chang P, Devuni D, Bichoupan K, Kesar V, Branch AD, Oh WK, et al. (2018). Real World Experience of Drug Induced Liver Injury in Patients Undergoing Chemotherapy. J Clin Gastroenterol Hepatol. 2(3):18. DOI: 10.21767/25757733.1000047.

Bouché M, Vincent B, Achard T, BelleminLaponnaz S. (2020). NHeterocyclic Carbene Platinum(IV) as Metallodrug Candidates: Synthesis and 195Pt NMR Chemical Shift Trend. Molecules. 25(14): 3148. Doi: 10.3390/molecules25143148.

Chu NH, Li L, Zhang X, Gu J, Du YD, Cai C, Xiao HP. (2015). Role of Bicyclol in Preventing DrugInduced Liver Injury in Tuberculosis Patients with Liver Disease. Int J Tuberc Lung Dis. 19(4):475. DOI: 10/5588/ijtld.14.0579.

Farhat, Adham M, Dewi YA, Indrasari SR, editor. (2014). Karsinoma Nasofaring. Penerbit Buku Kedokteran EGC.

Hang Z, Cooper MA, Ziora ZM. (2016). PlatinumBased Anticancer Drugs Encapsulated Liposome and Polymeric Micelle Formulation in Clinical Trials. Bio Chem Comp. 4:1–4. DOI: 10.7243/2052934142.

Komite Penanggulangan Kanker Nasional (2012). Pedoman Nasional Pelayanan Kedokteran Kanker Nasofaring. Kementerian Kesehatan Republik Indonesia.

Komite Penanggulangan Kanker Nasional (2017). Panduan Penatalaksanaan Kanker Nasofaring. Kementerian Kesehatan Republik Indonesia.

Lala V, Goyal A, Bansal P, Al E. (2020). Liver Function Tests. StatPearls.Treasure Isl StatPearls Publ.

Nasution AN, Aziz H, Tjong DH, Zein R. (2019). Effect of Phaleria macrocarpa Flesh Fruits Extract on MDA Level, SGOT and SGPT Activity in Serum of Experimental Rats Contaminated by Cd (II) Ion. Open Access Maced J Med Sci. 7(23):3950–3954. DOI: 10.3889/oamjms.2019.786.

Rehman MU, Rather IA. (2019). Myricetin Abrogates CisplatinInduced Oxidative Stress, Inflammatory Response, and Goblet Cell Disintegration in Colon of Wistar Rats. Plants (Basel, Switzerland), 9(1), 28. DOI: 10.3390/plants9010028

Santosa YI, Samiadi D, Aroeman NA, Fianza PI (2012). Pengaruh Alfa Tokoferol pada Efek Ototoksik Sisplatin. MKB,:205–12. DOI: 10.15395/mkb.v44n4.176.

Simo R, Robinson M, Lei M, Sibtain A, Hickey S. Nasopharyngeal carcinoma: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016 May;130(S2): S97S103. DOI: 10.1017/S0022215116000517.

Topik A (2014). Oxidatively Modified DNA Lesions and Systems for Reparation. Sources, Clinical Significance and Methods of Analysis. Omi Gr United States Am. 53–5.

Widiono KR, Yusmawan W, Naftali Z. (2017). Perbandingan Five Year Survival Rate Penderita Karsinoma Nasofaring pada Modalitas Kemoterapi dan Kemoradiasi. J Kedokt Diponegoro. 6.

Wu L, Li C, Pan L. (2018). Nasopharyngeal carcinoma: A review of current updates. Experimental and therapeutic medicine. 15(4): 3687–3692. DOI: 10.3892/etm.2018.5878.